156 related articles for article (PubMed ID: 29183992)
1. Structural basis for the recognition of kinesin family member 21A (KIF21A) by the ankyrin domains of KANK1 and KANK2 proteins.
Guo Q; Liao S; Zhu Z; Li Y; Li F; Xu C
J Biol Chem; 2018 Jan; 293(2):557-566. PubMed ID: 29183992
[TBL] [Abstract][Full Text] [Related]
2. Structural analyses of key features in the KANK1·KIF21A complex yield mechanistic insights into the cross-talk between microtubules and the cell cortex.
Weng Z; Shang Y; Yao D; Zhu J; Zhang R
J Biol Chem; 2018 Jan; 293(1):215-225. PubMed ID: 29158259
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into ankyrin repeat-mediated recognition of the kinesin motor protein KIF21A by KANK1, a scaffold protein in focal adhesion.
Pan W; Sun K; Tang K; Xiao Q; Ma C; Yu C; Wei Z
J Biol Chem; 2018 Feb; 293(6):1944-1956. PubMed ID: 29217769
[TBL] [Abstract][Full Text] [Related]
4. Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.
Li CC; Kuo JC; Waterman CM; Kiyama R; Moss J; Vaughan M
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19228-33. PubMed ID: 22084092
[TBL] [Abstract][Full Text] [Related]
5. A major mutation of KIF21A associated with congenital fibrosis of the extraocular muscles type 1 (CFEOM1) enhances translocation of Kank1 to the membrane.
Kakinuma N; Kiyama R
Biochem Biophys Res Commun; 2009 Sep; 386(4):639-44. PubMed ID: 19559006
[TBL] [Abstract][Full Text] [Related]
6. Nephrotic-syndrome-associated mutation of KANK2 induces pathologic binding competition with physiological interactor KIF21A.
Xu Y; Guo C; Pan W; Zhao C; Ding Y; Xie X; Wei Z; Sun Y; Yu C
J Biol Chem; 2021 Aug; 297(2):100958. PubMed ID: 34274317
[TBL] [Abstract][Full Text] [Related]
7. Talin2 and KANK2 functionally interact to regulate microtubule dynamics, paclitaxel sensitivity and cell migration in the MDA-MB-435S melanoma cell line.
Lončarić M; Stojanović N; Rac-Justament A; Coopmans K; Majhen D; Humphries JD; Humphries MJ; Ambriović-Ristov A
Cell Mol Biol Lett; 2023 Jul; 28(1):56. PubMed ID: 37460977
[TBL] [Abstract][Full Text] [Related]
8. CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor.
van der Vaart B; van Riel WE; Doodhi H; Kevenaar JT; Katrukha EA; Gumy L; Bouchet BP; Grigoriev I; Spangler SA; Yu KL; Wulf PS; Wu J; Lansbergen G; van Battum EY; Pasterkamp RJ; Mimori-Kiyosue Y; Demmers J; Olieric N; Maly IV; Hoogenraad CC; Akhmanova A
Dev Cell; 2013 Oct; 27(2):145-160. PubMed ID: 24120883
[TBL] [Abstract][Full Text] [Related]
9. Talin-KANK1 interaction controls the recruitment of cortical microtubule stabilizing complexes to focal adhesions.
Bouchet BP; Gough RE; Ammon YC; van de Willige D; Post H; Jacquemet G; Altelaar AM; Heck AJ; Goult BT; Akhmanova A
Elife; 2016 Jul; 5():. PubMed ID: 27410476
[TBL] [Abstract][Full Text] [Related]
10. KANK family proteins in cancer.
Tadijan A; Samaržija I; Humphries JD; Humphries MJ; Ambriović-Ristov A
Int J Biochem Cell Biol; 2021 Feb; 131():105903. PubMed ID: 33309958
[TBL] [Abstract][Full Text] [Related]
11. Kank proteins: a new family of ankyrin-repeat domain-containing proteins.
Zhu Y; Kakinuma N; Wang Y; Kiyama R
Biochim Biophys Acta; 2008 Feb; 1780(2):128-33. PubMed ID: 17996375
[TBL] [Abstract][Full Text] [Related]
12. Kank proteins: structure, functions and diseases.
Kakinuma N; Zhu Y; Wang Y; Roy BC; Kiyama R
Cell Mol Life Sci; 2009 Aug; 66(16):2651-9. PubMed ID: 19554261
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution and subcellular localization of the family of Kidney Ankyrin Repeat Domain (KANK) proteins.
Guo SS; Seiwert A; Szeto IYY; Fässler R
Exp Cell Res; 2021 Jan; 398(1):112391. PubMed ID: 33253712
[TBL] [Abstract][Full Text] [Related]
14. The interaction between KIF21A and KANK1 regulates dendritic morphology and synapse plasticity in neurons.
Sun SY; Nie L; Zhang J; Fang X; Luo H; Fu C; Wei Z; Tang AH
Neural Regen Res; 2025 Jan; 20(1):209-223. PubMed ID: 38767486
[TBL] [Abstract][Full Text] [Related]
15. Loss of the KN Motif and AnKyrin Repeat Domain 1 (KANK1) Leads to Lymphoid Compartment Dysregulation in Murine Model.
Almosailleakh M; Bentivegna S; Narcisi S; Benquet SJ; Gillberg L; Montaño-Almendras CP; Savickas S; Schoof EM; Wegener A; Luche H; Jensen HE; Côme C; Grønbæk K
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895296
[TBL] [Abstract][Full Text] [Related]
16. Force-Dependent Regulation of Talin-KANK1 Complex at Focal Adhesions.
Yu M; Le S; Ammon YC; Goult BT; Akhmanova A; Yan J
Nano Lett; 2019 Sep; 19(9):5982-5990. PubMed ID: 31389241
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
[TBL] [Abstract][Full Text] [Related]
18. Kank Is an EB1 interacting protein that localises to muscle-tendon attachment sites in Drosophila.
Clohisey SM; Dzhindzhev NS; Ohkura H
PLoS One; 2014; 9(9):e106112. PubMed ID: 25203404
[TBL] [Abstract][Full Text] [Related]
19. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
20. Association of liprin β-1 with kank proteins in melanoma.
Luo M; Mengos AE; Mandarino LJ; Sekulic A
Exp Dermatol; 2016 Apr; 25(4):321-3. PubMed ID: 26739330
[No Abstract] [Full Text] [Related]
[Next] [New Search]